Pages that link to "Q54470228"
Jump to navigation
Jump to search
The following pages link to Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer. (Q54470228):
Displaying 11 items.
- Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy (Q33659635) (← links)
- Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients (Q34341453) (← links)
- Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients (Q34996947) (← links)
- Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma (Q36673510) (← links)
- VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib (Q36746698) (← links)
- Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma. (Q37437235) (← links)
- Pharmacogenetics and breast cancer management: current status and perspectives (Q38358816) (← links)
- Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients (Q44039441) (← links)
- WITHDRAWN: Single nucleotide polymorphisms, haplotype association and tumour expression of the vascular endothelial growth factor (VEGF) gene with lung carcinoma (Q46714484) (← links)
- Vascular endothelial growth factor A gene (VEGFA) polymorphisms and expression of VEGFA gene in lung cancer patients of Kashmir Valley (India) (Q83200227) (← links)
- Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study (Q89534299) (← links)